Results 181 to 190 of about 479,454 (261)
Semi‐autonomous Navigation of Magnetic Microcarriers for Knee Cartilage Regeneration
Autonomous navigation of magnetic microcarriers in complex 3D environments is investigated through a semi‐autonomous strategy integrating magnetic actuation with monocular visual feedback. Real‐time global tracking is achieved via radio‐frequency‐based localization and depth estimation, while model‐based computation determines optimal steering forces ...
Kim Tien Nguyen +3 more
wiley +1 more source
Drowning in delays: a patient journey mapping analysis of child drowning care in rural India. [PDF]
Jagnoor J, Gupta M.
europepmc +1 more source
Abstract This study analyzes a participatory project to develop peer support services for people with serious mental illnesses (SMIs) in China. Drawing on interviews with psychiatrists, social workers, service users, and a family caregiver, it examines the conditions, challenges, facilitators, and outcomes of participation in a paternalistic context ...
Zhiying Ma +6 more
wiley +1 more source
Enhancing Post-Discharge Care for People Who Have Had an Acute Myocardial Infarction in Portugal: Insights From Patient Journey Mapping. [PDF]
Homem F +13 more
europepmc +1 more source
Prescriptions for Excellence in Health Care Winter 2013 Download pdf of full issue [PDF]
core +1 more source
ABSTRACT Mosunetuzumab is approved as an intravenous (IV) formulation for relapsed/refractory (R/R) follicular lymphoma (FL) after ≥ 2 prior therapies. A subcutaneous (SC) formulation, aiming to improve patient safety and convenience, has been developed.
Nancy L. Bartlett +20 more
wiley +1 more source
Patient journey and decision processes for anti-amyloid therapy in Alzheimer's disease. [PDF]
Mittler B +14 more
europepmc +1 more source
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia
ABSTRACT Preclinical studies showed a synergistic antileukemia activity with combination of selective XPO1 inhibitor selinexor (SEL) and venetoclax (VEN), with potential to overcome VEN resistance by reducing the anti‐apoptotic protein MCL1. In an investigator‐sponsored, open‐label, phase Ib study (NCT03955783), adult patients with relapsed or ...
Somedeb Ball +11 more
wiley +1 more source
Patient journey and treatment pattern in myasthenia gravis: real-world data from the Brazilian public health system. [PDF]
Scola RH.
europepmc +2 more sources

